Ethoheptazine

DB08988ApprovedWithdrawnSmall molecule

Ethoheptazine is marketed under the name Zactane. It is a phenazepine based opioid analgesic. It was invented in the 1950s and is related to other drugs such as proheptazine. Ethoheptazine... Ethoheptazine is no longer marketed in the United States.

Formula / weight: C₁₆H₂₃NO₂ · 261.3593 g/mol (avg)
First approval: Canada, 1995
Code names: Wy 401

Resolves to

Compound

UNII3A4G3A848UCAS77-15-6ChEMBLCHEMBL170797ChEBI135074PubChem6469KEGGD01435

Clinical / RWD

RxNorm24484

Structure

InChIKeyWGJHHMKQBWSQIY-UHFFFAOYSA-NSMILESCCOC(=O)C1(CCCN(C)CC1)C1=CC=CC=C1

What you can answer from here — as of September 16, 2026

1Marketed productAcross 1 country and 1 labeller

Which companies are running trials of Ethoheptazine, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account